home / stock / tern / tern articles

TERN Articles, Terns Pharmaceuticals Inc. - From 02/07/24

Stock Information
Company Name: Terns Pharmaceuticals Inc.
Stock Symbol: TERN
Market: NASDAQ
Website: ternspharma.com
Menu
TERN TERN Quote TERN Short TERN News TERN Articles TERN Message Board
Get TERN Alerts

News, Short Squeeze, Breakout and More Instantly...
Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer | Benzinga

FOSTER CITY, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage bi...
Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. Morgan Healthcare Conference | Benzinga

Plans to advance diverse pipeline of programs in oncology and metabolic diseases Anticipates key proof-of-concept readouts for TERN-701 (CML) and ...

Top 5 Health Care Stocks That Are Ticking Portfolio Bombs | Benzinga

As of Dec. 5, 2023, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in the...

Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of registered follow...
SAIC Reports Q3 Results, Joins Uber, Wallbox And Other Big Stocks Moving Higher On Monday | Benzinga

U.S. stocks traded lower, with the Dow Jones index falling more than 100 points on Monday. Shares of Science Applications International Corporation...

Terns Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Summit | Benzinga

FOSTER CITY, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage bi...

Terns Pharmaceuticals Mourns the Loss of Senthil Sundaram, Former Chief Executive Officer | Benzinga

FOSTER CITY, Calif., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage bi...
Terns Pharmaceuticals to Participate in Upcoming November Investor Conferences | Benzinga

FOSTER CITY, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage bi...

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) | Benzinga

FOSTER CITY, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage bi...

Terns Pharmaceuticals to Participate in Upcoming Investor Conferences | Benzinga

FOSTER CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage bi...
Previous 10 Next 10